Ceva (CEVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
UBS has initiated coverage of CEVA with a Buy rating and a $27 price target, noting that the semiconductor IP provider's growth outlook is not fully reflected in its valuation. The firm pointed to CEVA's strong position in connectivity intellectual property and an emerging opportunity in edge AI computing.
CEVA, Inc. (CEVA) Q4 2025 Earnings Call Transcript
Ceva (CEVA) came out with quarterly earnings of $0.18 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.11 per share a year ago.
CEVA, Inc. ( CEVA ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Richard Kingston - Vice President of Market Intelligence, Investor & Public Relations Amir Panush - CEO & Director Yaniv Arieli - CFO & Treasurer Conference Call Participants Chris Reimer - Barclays Bank PLC, Research Division Madison De Paola Martin Yang - Oppenheimer & Co. Inc., Research Division David O'Connor - BNP Paribas, Research Division Presentation Operator Good day, and welcome to the CEVA, Inc. Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note today's event is being recorded.
Ceva (CEVA) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.14 per share a year ago.
I rate CEVA a buy due to its promising growth prospects in connectivity and on-device AI, despite mixed factors like profitability and valuation. The company's "connect, sense, and infer" strategy targets edge AI, wireless connectivity, IoT, and 5G, with a diverse product suite driving recent momentum. CEVA's licensing model, with high gross margins and a focus on long-term royalty streams, supports sustained revenue growth in multiple solid end markets.
Niche electronics company Ceva (CEVA 4.54%) has been an outperformer on the stock exchange of late, according to data compiled by S&P Global Market Intelligence. On Tuesday the company announced a licensing deal, and investors flocked to snap up its shares.
France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion euros, as shareholders including the billionaire Bettencourt-Meyers family increased their stake, its chief executive said on Monday.
CEVA, Inc. (NASDAQ:CEVA ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Richard Kingston – Vice President-Market Intelligence and Investor and Public Relations Amir Panush – Chief Executive Officer Yaniv Arieli – Chief Financial Officer Conference Call Participants Kevin Cassidy – Rosenblatt Securities Suji Desilva – Roth Capital Gus Richard – Northland Chris Reimer – Barclays Operator Good day, and welcome to the CEVA Fourth Quarter and Year End 2024 Earnings Conference Call. All participants will be in listen-only mode.
Signal processing specialist Ceva (CEVA 1.18%) reported fourth-quarter results on Thursday, Feb. 13, that matched or exceeded analysts' consensus expectations. Total revenue of $29.2 million outperformed analysts' forecasts of $27 million while adjusted earnings per share (EPS) stood at $0.11, in line with forecasts and showing a 10% year-over-year increase.
CEVA, Inc. (NASDAQ:CEVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Richard Kingston - Vice President-Market Intelligence, Investor & Public Relations Amir Panush - Chief Executive Officer Yaniv Arieli - Chief Financial Officer Conference Call Participants Kevin Cassidy - Rosenblatt Securities Chris Reimer - Barclays Gus Richard - Northland Martin Yang - Oppenheimer Warren Darilek - D.A. Davidson Operator Good day, and welcome to the Ceva Inc. Third Quarter 2024 Earnings Conference Call.